Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil flag Brazil · Delayed Price · Currency is BRL
1.040
+0.010 (0.97%)
Sep 17, 2026, 5:05 PM GMT-3

BVMF:ONCO3 Cash Flow Statement

Millions BRL. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4,230-3,624-646.19223.6246.26-46.9
Depreciation & Amortization
240.26251.01275.45236.9175.15121.71
Other Amortization
53.9246.3950.9320.47-5.27
Loss (Gain) From Sale of Assets
434.33434.33----
Asset Writedown & Restructuring Costs
1,2601,151724.912.61.961.1
Loss (Gain) From Sale of Investments
496.75497.98----
Loss (Gain) on Equity Investments
19.87-0.187.911.650.54-
Stock-Based Compensation
24.5122.1827.6546.8411.0869.16
Provision & Write-off of Bad Debts
549.57218.18175.15163.2599.3148.71
Other Operating Activities
1,281968.7-175.66-250.16-92.558.96
Change in Accounts Receivable
-514.85-281.47-781.08-659.59-676.1-182.05
Change in Inventory
-0.7224.47-18.85-42.26-70.29-24.22
Change in Accounts Payable
750.79109.38217.79159.17262.5547.75
Change in Income Taxes
28.17-15.1477.3365.88-49.9819.13
Change in Other Net Operating Assets
-84.1378.61-120.19-29.9220.43-77.91
Operating Cash Flow
309.59-118.63-184.85-51.56-271.64-9.28
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-131.92-168.12-214.25-311.7-300.18-201.95
Cash Acquisitions
-72.11-76.74-213.05-46.36-823.36-402.5
Investment in Securities
168.931,032-1,283556.09721.37-1,431
Other Investing Activities
81.965.76-10.5429.8-8.295.93
Investing Cash Flow
46.86793.03-1,721227.83-410.46-2,030

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-310.122,0441,5541,4391,188
Long-Term Debt Repaid
--778.51-1,333-598.06-831.91-544.34
Lease Payments
-40.31-43.45-49.29-52.49-83.98-25.51
Net Debt Issued (Repaid)
-324.44-468.39711.26956.15607.39643.31
Issuance of Common Stock
1.091.091,5002052.671,788
Repurchase of Common Stock
--3.69--33.74-65.02-177.09
Common Dividends Paid
-29.57-36.78-11.66-59.71-18.29-26.4
Other Financing Activities
-202.41-210.02-294.19-956.29-117.93-393.48
Financing Cash Flow
-555.33-717.781,905111.42408.821,835

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.072.180.57-0.19-0.350.42
Net Cash Flow
-198.94-41.20.04287.5-273.63-204.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
177.67-286.75-399.1-363.26-571.82-211.23
Free Cash Flow Growth
------
Free Cash Flow Margin
3.56%-5.00%-6.41%-6.62%-13.99%-7.82%
Free Cash Flow Per Share
0.20-0.33-0.65-0.68-1.07-0.51
Levered Free Cash Flow
-676.82-467.4112.91-615.49-329.02-161.29
Unlevered Free Cash Flow
-287.82-62.33468.01-263.37-22.7-64.81
Free Cash Flow After Leases
137.36-330.19-448.38-415.75-655.8-236.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
452689.64608490.63348.55128.78
Cash Income Tax Paid
8.550.8381.8295.9860.4433.5
Change in Working Capital
179.25-84.15-624.99-506.73-513.39-217.29